Newswise — Todd Margolis, MD, PhD (University of California-San Francisco) is the new president of the Association for Research in Vision and Ophthalmology, taking over from Martine Jager, MD, PhD (Leiden University, The Netherlands), whose one-year term ended in April.

Donald Hood, PhD (Columbia University) and Barry Winkler, PhD (Oakland University) will serve as vice presidents. Nicholas Delamere, PhD (University of Arizona) has been named president-elect; he will serve the 2009-2010 term. Paul Sternberg, MD (Vanderbilt Eye Institute) is vice-president elect for that term.

In addition, ARVO members voted two new section trustees to the board. Jacob Pe'er, MD (Hadassah-Hebrew University Medical Center, Jerusalem, Israel) is the new Anatomy/Pathology (AP) trustee. Peng Tee Khaw, MD, PhD (Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK) will represent the Glaucoma (GL) Section on the board.

"During the coming year," said Margolis, "I'm looking forward to working with the ARVO staff and Board of Trustees to bring greater value to the ARVO membership. ARVO is a great organization with an amazing diversity of scientists as members and a unique collegiality. It should be a fun and productive year."

Biographical sketches

President: Todd P. Margolis, MD, PhDMargolis is a professor of ophthalmology and director of the Francis I. Proctor Foundation at the University of California, San Francisco (UCSF). He received his MD and completed his PhD in neuroscience at UCSF. As an active clinician, he pursues clinical research aimed at understanding the pathogenic mechanisms leading to atypical clinical presentations of herpes virus eye disease. Margolis serves on the National Advisory Eye Council of the NEI and is a member of the American Academy of Ophthalmology, the American Society for Microbiology and the Society for Neuroscience. He has been an ARVO member since 1984 and ARVO trustee for Immunology and Microbiology since 2004. He is the chair of the ARVO CME Committee and past chair of the ARVO Commercial Relationships Committee. He also served on the IM Section Annual Meeting Program Committee, 1998"2000.

Vice President: Donald Hood, PhD Hood is the James F. Bender Professor of Psychology at Columbia University in New York, NY. He received his PhD from Brown University. His research interests include psychophysical and electrophysiological assessment of diseases of the retina and ganglion cell/optic nerve. Hood has been an ARVO member since 1970, attending each of the last 39 Annual Meetings and serving as the ARVO trustee for Visual Psychophysics/Physiological Optics since 2004. He is the chair of the ARVO Finance Committee and serves on the editorial boards of Investigative Ophthalmology and Visual Science and Journal of Vision.He served on the VI Section Annual Meeting Program Committee, 1978"1981.

Vice President: Barry S. Winkler, PhD Winkler is professor of biomedical sciences in the Eye Research Institute at Oakland University. He received his BA in biology from Harpur College (now SUNY at Binghamton) in 1965 and conducted his MA and PhD work at the University of Buffalo Medical School in physiology under Professor Werner K. Noell. His research interests include studies on models of energy metabolism in retinal neurons, glial cells and the retinal pigment epithelium, oxidation processes and retinal detachment. He served as a member and chairperson of the NIH Visual Sciences C Study Section from 1990 to 1995. Winkler has been an ARVO member since 1972, and has served as ARVO trustee for Retinal Cell Biology since 2004. He is the chair of the ARVO Advocacy Committee and served on the editorial board of Investigative Ophthalmology and Visual Science from 1997 to 2002.

President-Elect: Nicholas A. Delamere, PhD Delamere, an internationally renowned authority on ion transport proteins in the eye, is a head of the Department of Physiology and a professor at the University of Arizona, which he joined in 2006. After receiving his doctorate at the University of East Anglia in his native England, Delamere brought his work on membrane transport physiology to the University of Colorado in 1976 and later moved to the University of Louisville, where he received the President's Award for Outstanding Scholarship, Research and Creative Activity. He was also a recipient of the Research to Prevent Blindness Inc. Senior Scientific Investigator Award. He has served as vice president of the International Society for Eye Research, is the current chair of the ARVO Publications Committee and has been a member of the editorial board of Investigative Ophthalmology and Visual Science since 1992.

Vice President-Elect: Paul Sternberg, Jr., MD Sternberg is George W. Hale Professor and Chair of the Vanderbilt Eye Institute. He oversees a clinical and laboratory research program studying the pathogenesis of age-related macular degeneration. The author and/or co-author of 225 publications, 32 chapters, and two books, Sternberg completed his medical degree with honors from the University of Chicago/Pritzker School of Medicine. He is a recipient of the American Academy of Ophthalmology Senior Honor Award, the Vitreous Society Honor Award, the L.E. Brown Humanitarian Award from the Georgia Society of Ophthalmology and the Heed Ophthalmic Foundation Award. He is on the Board of Trustees at the American Academy of Ophthalmology and is a former member of the National Eye Institute's Board of Scientific Councilors. He currently serves on the ARVO Finance, Exhibits and Long Range Planning Committees, and previously served on the RE Section Annual Meeting Program Committee. He was also a past member of the Editorial Board of Investigative Ophthalmology and Visual Science.

Anatomy/Pathology Trustee: Jacob Pe'er, MD Pe'er is a professor and chairman, Department of Ophthalmology, Hadassah-Hebrew University Medical Center, and associate dean, Hebrew University-Hadassah Faculty of Medicine; both in Jerusalem, Israel. He is a graduate of the Hadassah-Hebrew University School of Medicine. His research interests include ocular cell proliferation in normal and diseased tissue and intraocular and ocular adnexal tumors. He is a member of the European Association for Vision and Eye Research; International Society of Eye Research and the American Academy of Ophthalmology; president, International Society of Ocular Oncology;past president, International Society of Ophthalmic Pathology; and a member of the advisory board and chairman of the committee of countries with minimal presence of ophthalmology for the International Council of Ophthalmology. Pe'er has been an ARVO member since 1983. He is the past president of the Israel Society for Eye and Vision Research (an International Chapter Affiliate of ARVO). He serves on the ARVO International Chapter Affiliate Council and is on the Editorial Board of Investigative Ophthalmology and Visual Science. He is past chair of the ARVO International Members Committee and has also served on the AP Section Annual Meeting Program and the Long Range Planning Committees.

Glaucoma Trustee: Peng Tee Khaw MD, PhDKhaw is professor of Glaucoma and Ocular Healing and the director of the UK National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and The UCL Institute of Ophthalmology in London. His research interests include glaucoma surgery techniques, ocular scarring, stem cell therapy and tissue regeneration. Khaw was elected Fellow of the British Academy of Medical Sciences in 2003 and the Institute of Biologists 2000 and is a fellow of the Royal College of Ophthalmologists, Royal College of Physicians (UK) and Surgeons (England), and Royal College of Pathologists and member of the American Academy of Ophthalmology and Glaucoma Research Society. He has served on the Wellcome Trust Neurosciences Study Section, scientific advisory board Fight for Sight (UK) and grants committee UK National lottery and International Glaucoma Association and several editorial boards. He was the recipient of the ARVO/Pfizer Ophthalmic Translational Research Award, the Alcon Institute Research Award, and the Lang Medal of the Royal Society of Medicine. Khaw has been an ARVO member since 1990 and served on the Glaucoma Section Annual Meeting Program Committee from 2002 to 2005.

ARVO is the largest eye and vision research organization in the world. Members include more than 12,500 eye and vision researchers from over 70 countries. The Association encourages and assists research, training, publication and dissemination of knowledge in vision and ophthalmology. For more information, visit www.arvo.org.